-
What is the diagnostic accuracy of antibody tests for the detection of infection with the COVID‐19 virus?BackgroundCOVID‐19 is an infectious disease caused by the SARS‐CoV‐2 virus that spreads easily between people in a similar way to the common cold or ‘flu’. Most people with COVID‐19 have a mild‐to‐moderate respiratory illness, and some may have...
November 21 2022
-
In this ‘Meet the CIDG staff’ feature we chat with Tilly Fox, who joined the CIDG editorial base as a Research Assistant in June 2021. In June 2022, Tilly was appointed CIDG Review Synthesis Delivery Specialist, responsible for guiding Cochrane Reviews through the production and publication cycle and providing support to review authors. Tilly has...
November 21 2022
-
Which permanent and temporary changes to the water environments of immature mosquitoes work better to reduce malaria in people?Why is it important to reduce malaria in people?Malaria has a very high impact on the health of the public, mostly in people in Africa and Asia. Strategies to reduce malaria have been studied for many years. Most...
November 14 2022
-
Warm congratulations to Cochrane Infectious Diseases Group (CIDG) Editor Dr Eleanor Ochodo-Opondo, for winning Cochrane's prestigious 2022 Kenneth Warren Prize. This prize is awarded annually to a Cochrane Review author publishing on a health issue relevant to low-and middle-income countries (LMICs), which is of high methodological quality.Every...
November 7 2022
-
(First published on 20 March 2019; updated on 24 March 2020, 23 March 2021, 23 March 2022 on the Cochrane Library, and updated 7 November 2022 on the CIDG website)Tuberculosis continues to cause great suffering worldwide. It is expected that once the data are compiled, tuberculosis will rank second as a cause of death from a single...
November 2 2022
-
During October 2022, the CIDG published one updated review, in Issue 10 2022 of the Cochrane Database of Systematic Reviews. Further details are below.Updated review Fox T, Furnival-Adams J, Chaplin M, Napier M, Olanga EA. House modifications for preventing malaria. Cochrane Database of Systematic Reviews 2022, Issue 10. Art. No.:...
October 31 2022
-
Installing mosquito screening over house windows and closing the gaps in house eaves can help reduce infection with Plasmodium parasites and the number of people with anaemia in the household, according to an updated Cochrane Review published this week. Householders can implement many of these house modifications themselves, providing a...
October 6 2022
-
During September 2022, the CIDG published one new protocol, one new review, and two review updates in Issue 9, 2022 of the Cochrane Database of Systematic Reviews. New ProtocolPérez-Gaxiola G, Velásquez-Salazar P, Veroniki AA, Zambrano-Rico S, Hernández Alcaraz M, Cuello-García CA, Florez ID. Interventions for treating head lice: a...
October 5 2022
-
Is the combination nirmatrelvir plus ritonavir effective for treating or preventing COVID‐19?Key messagesNirmatrelvir/ritonavir (Paxlovid®) is evaluated for the treatment of coronavirus disease 2019 (COVID‐19).Nirmatrelvir/ritonavir may lead to fewer deaths and improve patient condition, as assessed by need for hospitalization or death within 28...
September 20 2022
-
This year the Cochrane Database of Systematic Reviews (CDSR) Journal Impact Factor is 12.008; this is an increase on the 2020 Journal Impact Factor which was 9.289. In addition, our (unofficial) CIDG impact factor is 34.275 (40 publications cited 1371 times). This is great news for the CIDG and justifies our strategy...
September 14 2022
What is the diagnostic accuracy of antibody tests for the detection of infection with the COVID‐19 virus?BackgroundCOVID‐19 is an infectious disease caused by the SARS‐CoV‐2 virus that spreads easily between people in a similar way to the common cold or ‘flu’. Most people with COVID‐19 have a mild‐to‐moderate respiratory illness, and some may have...November 21 2022
In this ‘Meet the CIDG staff’ feature we chat with Tilly Fox, who joined the CIDG editorial base as a Research Assistant in June 2021. In June 2022, Tilly was appointed CIDG Review Synthesis Delivery Specialist, responsible for guiding Cochrane Reviews through the production and publication cycle and providing support to review authors. Tilly has...November 21 2022
Which permanent and temporary changes to the water environments of immature mosquitoes work better to reduce malaria in people?Why is it important to reduce malaria in people?Malaria has a very high impact on the health of the public, mostly in people in Africa and Asia. Strategies to reduce malaria have been studied for many years. Most...November 14 2022
Warm congratulations to Cochrane Infectious Diseases Group (CIDG) Editor Dr Eleanor Ochodo-Opondo, for winning Cochrane's prestigious 2022 Kenneth Warren Prize. This prize is awarded annually to a Cochrane Review author publishing on a health issue relevant to low-and middle-income countries (LMICs), which is of high methodological quality.Every...November 7 2022
(First published on 20 March 2019; updated on 24 March 2020, 23 March 2021, 23 March 2022 on the Cochrane Library, and updated 7 November 2022 on the CIDG website)Tuberculosis continues to cause great suffering worldwide. It is expected that once the data are compiled, tuberculosis will rank second as a cause of death from a single...November 2 2022
During October 2022, the CIDG published one updated review, in Issue 10 2022 of the Cochrane Database of Systematic Reviews. Further details are below.Updated review Fox T, Furnival-Adams J, Chaplin M, Napier M, Olanga EA. House modifications for preventing malaria. Cochrane Database of Systematic Reviews 2022, Issue 10. Art. No.:...October 31 2022
Installing mosquito screening over house windows and closing the gaps in house eaves can help reduce infection with Plasmodium parasites and the number of people with anaemia in the household, according to an updated Cochrane Review published this week. Householders can implement many of these house modifications themselves, providing a...October 6 2022
Is the combination nirmatrelvir plus ritonavir effective for treating or preventing COVID‐19?Key messagesNirmatrelvir/ritonavir (Paxlovid®) is evaluated for the treatment of coronavirus disease 2019 (COVID‐19).Nirmatrelvir/ritonavir may lead to fewer deaths and improve patient condition, as assessed by need for hospitalization or death within 28...September 20 2022
This year the Cochrane Database of Systematic Reviews (CDSR) Journal Impact Factor is 12.008; this is an increase on the 2020 Journal Impact Factor which was 9.289. In addition, our (unofficial) CIDG impact factor is 34.275 (40 publications cited 1371 times). This is great news for the CIDG and justifies our strategy...September 14 2022